一品红：12月29日召开董事会会议

Group 1 - The core viewpoint of the news is that Yipin Hong (SZ 300723) held its 16th board meeting on December 29, 2025, to discuss the proposal for the first extraordinary shareholders' meeting of 2026 [1] - For the year 2024, Yipin Hong's revenue composition is as follows: 96.78% from pharmaceutical manufacturing and 3.22% from pharmaceutical agency [1] Group 2 - As of the report, Yipin Hong has a market capitalization of 15.6 billion yuan [2]